Showing 1 of 1 PublicationsSwitching From Rosiglitazone: Thinking Outside the ClassLipska KJ, Ross JS. Switching From Rosiglitazone: Thinking Outside the Class. JAMA 2011, 305: 820-821. PMID: 21304068, DOI: 10.1001/jama.2011.193.Commentaries, Editorials and LettersCitationsMeSH KeywordsBlood GlucoseCardiovascular DiseasesDecision MakingDiabetes MellitusDrug LabelingEvidence-Based MedicineHeart FailureHumansHypoglycemic AgentsPioglitazoneRiskRosiglitazoneThiazolidinedionesDownload Full List
Switching From Rosiglitazone: Thinking Outside the ClassLipska KJ, Ross JS. Switching From Rosiglitazone: Thinking Outside the Class. JAMA 2011, 305: 820-821. PMID: 21304068, DOI: 10.1001/jama.2011.193.Commentaries, Editorials and LettersCitationsMeSH KeywordsBlood GlucoseCardiovascular DiseasesDecision MakingDiabetes MellitusDrug LabelingEvidence-Based MedicineHeart FailureHumansHypoglycemic AgentsPioglitazoneRiskRosiglitazoneThiazolidinediones